Calumet Inc (CLMT)

NASD · Basic Materials · Specialty Chemicals · USA

Calumet Inc is a mid cap company (market value between $2 billion and $10 billion) in the Specialty Chemicals industry.

Calumet manufactures and markets specialty products and renewable fuels to consumer-facing and industrial customers across North America. The company produces solvents, waxes, lubricating oils and petrolatums through its Specialty Products segment; sells performance products under Royal Purple, Bel-Ray, and TruFuel brands; and converts renewable feedstocks into renewable diesel and sustainable aviation fuel.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Calumet Inc stock.

Our verdict on CLMT

Overvalued: intrinsic value $15.07 per share, market price $55.54, margin of safety -268.5% (as of 2026-10-19).

Discounting its cash flows at 8.1% (average of 2 methods) values the shares at $15.07; the price of $55.54 is 268% above that value, and 79% of that value comes from beyond year five.

ETFs with the most weight in CLMT

17 more funds hold it; the full list is part of the paid plan.

More on CLMT

Browse

Peers in Specialty Chemicals

All 62 Specialty Chemicals stocks

Cheaper than CLMT in Specialty Chemicals

30 more in this industry show a wider margin of safety.

Is CLMT undervalued or overvalued?

CLMT is overvalued (as of the 2026-10-19 close). Discounting its cash flows at 8.1% (average of 2 methods) values the shares at $15.07; the price of $55.54 is 268% above that value, and 79% of that value comes from beyond year five.

What is the intrinsic value of CLMT?

$15.07 per share (as of the 2026-10-19 close), against a market price of $55.54. That is a margin of safety of -268.5%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.